| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| keytruda nsclc approval | 0.96 | 0.9 | 9243 | 88 | 23 |
| keytruda | 0.05 | 0.3 | 2241 | 69 | 8 |
| nsclc | 1.52 | 0.6 | 5108 | 56 | 5 |
| approval | 1.24 | 0.9 | 2322 | 72 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| keytruda nsclc approval | 1.54 | 0.9 | 6586 | 93 |
| fda approval keytruda adjuvant nsclc | 1.51 | 1 | 7334 | 27 |
| keytruda fda approval 2021 | 0.18 | 0.3 | 9004 | 13 |
| keytruda fda approval date | 1.99 | 0.4 | 7003 | 93 |
| fda approval history for keytruda | 1.43 | 0.6 | 3927 | 94 |
| keytruda for metastatic nsclc | 0.88 | 0.6 | 7029 | 4 |
| keytruda breast cancer approval | 0.85 | 0.4 | 8218 | 62 |
| is keytruda fda approved | 1.13 | 0.3 | 6807 | 41 |
| keytruda first approval date | 1.59 | 0.1 | 9456 | 26 |
| adjuvant keytruda breast cancer | 1.53 | 0.1 | 4707 | 11 |
| keytruda cervical cancer approval | 1.07 | 0.9 | 6474 | 50 |
| when was keytruda approved by the fda | 1 | 0.4 | 8863 | 32 |
| neoadjuvant keytruda breast cancer | 0.23 | 0.2 | 5680 | 58 |
| clinical trials and eligibility for keytruda | 0.21 | 0.2 | 3243 | 2 |
| keytruda pancreatic cancer approval | 0.33 | 0.9 | 4060 | 76 |
| keytruda gastric cancer approval | 1.59 | 0.6 | 848 | 96 |
| keytruda head and neck cancer approval | 1.2 | 0.5 | 7583 | 35 |
